Inventor · disambiguated record
Alex Burgin
Also filed as: BURGIN ALEX · BURGIN ALEX B · BURGIN ALEX BUNTIN · BURGIN JR ALEX B
15 granted patents·10 pending applications·703 citations·filing 1995–2020
94Inventor score
Files withRIBOZYME PHARM INC8SINGH JASBIR5DECODE GENETICS EHF4EMERALD BIOSTRUCTURES INC2DECODE BIOSTRUCTURES INC1
Top patents by PatentIndex Score
25 records- 0196US6617438B1Oligoribonucleotides with enzymatic activitySIRNA THERAPEUTICS INC·Filed 1999·Granted Sep 9, 2003·312 cites·27 claims
- 0296US6528640B1Synthetic ribonucleic acids with RNAse activityRIBOZYME PHARM INC·Filed 1999·Granted Mar 4, 2003·283 cites·3 claims
- 0393US10775385B2Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimersUCB BIOPHARMA SPRL·Filed 2015·Granted Sep 15, 2020·7 cites·4 claims
- 0492US11674967B2Method of identifying potential inhibitors of APO TNFα trimersUCB Biopharma SRL·Filed 2020·Granted Jun 13, 2023·2 cites·19 claims
- 0580US6951720B2Use of phosphorothiolate polynucleotides in ligating nucleic acidsEMERALD BIOSTRUCTURES INC·Filed 2001·Granted Oct 4, 2005·14 cites·16 claims
- 0679US8791267B2Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disordersSINGH JASBIR·Filed 2012·Granted Jul 29, 2014·4 cites·22 claims
- 0777US6509460B1Nucleoside triphosphates and their incorporation into oligonucleotidesRIBOZYME PHARM INC·Filed 2000·Granted Jan 21, 2003·4 cites·12 claims
- 0873US8883833B2Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disordersSINGH JASBIR·Filed 2008·Granted Nov 11, 2014·1 cites·28 claims
- 0970US6127535ANucleoside triphosphates and their incorporation into oligonucleotidesRIBOZYME PHARM INC·Filed 1998·Granted Oct 3, 2000·23 cites·20 claims
- 1067US5672501ABase-modified enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1995·Granted Sep 30, 1997·20 cites·16 claims
- 1166US6482932B1Nucleoside triphosphates and their incorporation into oligonucleotidesRIBOZYME PHARM INC·Filed 1999·Granted Nov 19, 2002·21 cites·20 claims
- 1265US2009136473A1Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disordersDECODE GENETICS EHF·Filed 2008·Application pending·0 cites
- 1364US2009324569A1Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disordersDECODE GENETICS EHF·Filed 2008·Application pending·0 cites
- 1461US2014301999A1Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disordersDECODE GENETICS EHF·Filed 2014·Application pending·0 cites
- 1557US2012213758A1Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disordersSINGH JASBIR·Filed 2012·Application pending·0 cites
- 1657US2014275553A1Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disordersDECODE GENETICS EHF·Filed 2014·Application pending·0 cites
- 1753US2003170644A1Method for screening nucleic acid catalystsRIBOZYME PHARM INC·Filed 2002·Application pending·0 cites
- 1852US2012207729A1Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disordersSINGH JASBIR·Filed 2012·Application pending·0 cites
- 1950US7587284B2Gene synthesis softwareDECODE BIOSTRUCTURES INC·Filed 2006·Granted Sep 8, 2009·0 cites·8 claims
- 2049US6280936B1Method for screening nucleic acid catalystsRIBOZYME PHARM INC·Filed 1998·Granted Aug 28, 2001·7 cites·24 claims
- 2148US8877816B24-(or 5-) substituted catechol derivativesSINGH JASBIR·Filed 2008·Granted Nov 4, 2014·0 cites·29 claims
- 2247US6548657B1Method for screening nucleic acid catalystsRIBOZYME PHARM INC·Filed 1998·Granted Apr 15, 2003·5 cites·24 claims
- 2346US2003144489A1Method for screening nucleic acid catalystsFiled 2002·Application pending·0 cites
- 2444US2005003502A1Structures and methods for designing topoisomerase I inhibitorsEMERALD BIOSTRUCTURES INC·Filed 2001·Application pending·0 cites
- 2543US2003004122A1Nucleotide triphosphates and their incorporation into oligonucleotidesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alex Burgin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →